Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with (212)Pb alpha-radioimmunotherapy targeting CD20.

Quelven I, Saidi A, Sage M, Mora-Ramirez E, Torgue J, Cogne M, Durand-Panteix S

DOI: 10.1186/s13550-025-01349-w
Published: 2025 Dec 5
Container: EJNMMI research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13550-025-01349-w,
  title = {Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with (212)Pb alpha-radioimmunotherapy targeting CD20.},
  author = {Quelven I and Saidi A and Sage M and Mora-Ramirez E and Torgue J and Cogne M and Durand-Panteix S},
  year = {2025},
  journal = {EJNMMI research},
  doi = {10.1186/s13550-025-01349-w},
  url = {https://doi.org/10.1186/s13550-025-01349-w}
}

RIS

TY  - JOUR
TI  - Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with (212)Pb alpha-radioimmunotherapy targeting CD20.
AU  - Quelven I
AU  - Saidi A
AU  - Sage M
AU  - Mora-Ramirez E
AU  - Torgue J
AU  - Cogne M
AU  - Durand-Panteix S
PY  - 2025
JO  - EJNMMI research
DO  - 10.1186/s13550-025-01349-w
UR  - https://doi.org/10.1186/s13550-025-01349-w
ER  -

APA

I, Q., A, S., M, S., E, M., J, T., M, C., & S, D. (2025). Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with (212)Pb alpha-radioimmunotherapy targeting CD20.. EJNMMI research. https://doi.org/10.1186/s13550-025-01349-w

Source records

pubmed · retrieved 2026-09-26T13:00:11.811Z